Experimental Design The study consists of two prospective cohort arms. A dose timing cohort to develop the pharmacokinetic profile for blood and CSF concentrations, and a dose escalation cohort in which increasing doses of a celecoxib suspension will be administered. A single blood sample to determine the CYP2C9 alleles will be drawn from each patient upon study entry.